Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Operations and Comprehensive Loss

v3.3.1.900
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Operating Expenses    
Research and development $ 435,671 $ 232,032
Professional and consulting fees 261,350 165,302
General and administrative 167,747 95,699
Share-based compensation expense (Notes 8(v) and 9) 371,637 0
Depreciation (Note 5) 10,412 423
Total operating expenses 1,246,817 493,456
Other expenses (income)    
Imputed interest Expense (Note 6) 0 45,063
Interest Expense 179 17,124
Other Income (323) (473,162)
Foreign exchange Loss 0 0
Change in fair value of warrant derivative liability (Note 10) 6,387,473 0
Total other expense (income) 6,387,329 (410,975)
Net loss for the period (7,634,146) (82,481)
Foreign exchange translation adjustment for the period 24,799 18,837
Net loss and comprehensive loss for the period $ (7,609,347) $ (63,644)
Loss per share - basic and diluted $ (0.14) $ 0.00
Weighted average number of shares outstanding 52,726,746 36,621,885